Implications for drugmakers and insurers: GLP-1 medications offer promise for the estimated 4 in 10 US adults with obesity, but short-term use delivers short-lived results
[DOI] [PMC free article] [PubMed] [Google Scholar] 35.Fricker L.D., Devi L.A
While tirzepatide reduces appetite and calorie intake, L-carnitine theoretically optimizes fat oxidation during the calorie deficit that results
Research-Only : Exclusively for in vitro laboratory research
It rapidly interacts with and neutralizes a wide spectrum of reactive oxygen species (ROS) and reactive nitrogen species (RNS), including superoxide anions, destructive hydroxyl radicals, and peroxynitrite
Another strategy involves the use of PARP inhibitor BGP-15, which might protect against CC, to enhance mitochondrial homeostasis 260,261